PRATT v. ANN KLEIN FORENSIC CENTER

CourtDistrict Court, D. New Jersey
DecidedJuly 25, 2019
Docket3:15-cv-05779
StatusUnknown

This text of PRATT v. ANN KLEIN FORENSIC CENTER (PRATT v. ANN KLEIN FORENSIC CENTER) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
PRATT v. ANN KLEIN FORENSIC CENTER, (D.N.J. 2019).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

LINDA PRATT, individually and as a personal representative on behalf of TARIK Civ. No. 15-5779 PRATT, an incompetent person, OPINION Plaintiff,

v.

ANN KLEIN FORENSIC CENTER et al.,

Defendants.

THOMPSON, U.S.D.J. INTRODUCTION This matter comes before the Court upon the Motion for Summary Judgment filed by Defendants Ann Klein Forensic Center (“AKFC”), Ancora Psychiatric Hospital (“Ancora”), Dr. Safeer Ansari, Dr. Dariusz Chacinski, Linda Elias, Dr. Elaine Martin, and Dr. Benito Marty (collectively, “Defendants”). (ECF No. 92.) Plaintiff Linda Pratt (“Plaintiff”), individually and on behalf of her son Tarik Pratt (“Tarik”), opposes. (ECF No. 94.) The Court has decided the Motion based on the parties’ written submissions and without oral argument, pursuant to Local Civil Rule 78.1(b). For the reasons stated herein, Defendants’ Motion for Summary Judgment is granted in part and denied in part. BACKGROUND Plaintiff brings this action as a representative on behalf of her son, Tarik, an incompetent person who was civilly committed at Defendants AKFC and Ancora, two psychiatric hospitals located in New Jersey, due to a traumatic brain injury he had suffered years before. (Defs.’ 1 Statement of Undisputed Material Facts (“SUMF”) ¶¶ 1–2, ECF No. 92-2.) Tarik first became a patient at Defendant AKFC on June 2, 2011. (Id. ¶ 3.) On May 8, 2015, he was transferred from Defendant AKFC to Defendant Ancora, but on October 28, 2015, he was transferred back to Defendant AKFC. (Id. ¶¶ 4–5.) Plaintiff alleges that during Tarik’s stay at these two facilities,

he was subject to (1) isolation and seclusion; (2) abuse, neglect, and retaliation; and (3) overmedication. (See Defs.’ Br. at 2–3, ECF No. 92-1.) I. Isolation and Seclusion: Defendants Chacinksi and AKFC Defendant Chacinski, a staff clinical psychiatrist at Defendant AKFC, began treating Tarik when he was transferred to his unit on June 13, 2011, shortly after Tarik arrived at Defendant AKFC. (Pl.’s Suppl. SUMF at 8, ECF No. 94-2.) Defendant Chacinksi referred to Tarik as agitated, irrelevant, talking with no sense, and paranoid. (Id.) In order to make him more sedated and less agitated, he prescribed Thorazine on August 25, 2011. (Id. at 8–9.) Thorazine is a medication that can be used as an antidepressant, antipsychotic, or mood stabilizer. (Ansari Dep. 19:15–19, ECF No. 94-16.) Because he was “still psychotic and

agitated,” Tarik’s dosage of Thorazine was gradually increased until it reached 600 milligrams per day on September 12, 2011. (Pl.’s Suppl. SUMF at 9; Chacinski Dep. 38:19–39:8, ECF No. 94-6.) After that, the dosage was gradually decreased until January 11, 2012, when Tarik was taken off Thorazine completely and transferred to another psychotropic drug. (Pl’s Suppl. SUMF at 16, 20.) During the weekend of September 16, while Tarik was still on Thorazine, staff members found him engaging in sexual conduct with another patient. (Id. at 9–10; Chacinski Dep. 39:18– 40:16; see also Incident Report 1, ECF No. 94-9; Incident Report 2, ECF No. 94-10.) Three days later on September 19, Defendant Chacinksi transferred Tarik to Unit 2, an intensive 2 treatment unit (“ITU”) typically reserved for violent or self-injurious patients requiring more supervision. (Pl.’s Suppl. SUMF at 2, 9.) Defendant Chacinski described Tarik as psychotic, delusional, and unstable at the time. (Chacinski Dep. 39:18–40:16.) Plaintiff contends that Defendant Chacinski violated Tarik’s substantive due process rights of care and protection by

placing him in more restrictive housing than necessary as punishment for in-facility conduct that violated the institution’s rules or policies. (Pl.’s Br. at 14, 29, ECF No. 94.) Plaintiff also argues that Defendant AKFC discriminated against Tarik by keeping him in ITU for longer than necessary. (Id. at 22–22.) II. Alleged Abuse, Neglect, and Retaliation: Defendant AKFC On October 28, 2011, Plaintiff’s counsel wrote a letter to Defendant AKFC requesting reports, notes, and documents relating to the incident on the weekend of September 16, 2011. (Request Letter, ECF No. 94-13.) On December 6, 2011, Plaintiff’s counsel submitted to Defendant AKFC a document purporting to be a Notice of Tort Claim pursuant to the New Jersey Tort Claims Act, N.J.S.A. § 59:8-4. (Notice Letter, ECF No. 94-15.) After the Notice of

Tort Claim was served, Plaintiff contends that staff members at Defendant AKFC abused Tarik in retaliation. (Pl.’s Suppl. SUMF at 28.) For example, she avers that Tarik told her that staff members at Defendant AKFC punched Tarik in the eye, starved him, encouraged him to punch walls causing abrasions on his knuckles, neglected him to the point of contracting MRSA and sleeping in his own urine, hit him during the night, shackled and restrained him, and held him while other patients punched him.1 (Id. at 28–29.) Defendants dispute these allegations of abuse.

1 Plaintiff also alleged that staff members at Defendant AKFC broke Tarik’s glasses and delayed replacing them, but she abandoned that claim in her Opposition. (See Pl.’s Br. at 15.) 3 III. Alleged Overmedication: Defendant Ansari Plaintiff alleges that Defendant Ansari prescribed an inappropriate amount of Thorazine to Tarik while he was treating him at Defendant Ancora in 2015. Defendant Ansari had been a staff clinical psychiatrist at Defendant Ancora since 2012. (Pl.’s Suppl. SUMF at 20.) He

became responsible for Tarik’s medication on May 8, 2015, the day Tarik was transferred to Defendant Ancora. (Id. at 20–21.) Over the next few months, Tarik was involved in several physical altercations, demonstrating a propensity for violence and aggression. (Id. at 21–22.) Because he was gradually getting worse, on August 31, 2015, Defendant Ansari ordered that Tarik take fifty milligrams of Thorazine four times per day. (Id. at 22.) Defendant Ansari explained the rationale for the decision: We were looking for something that would work to help him calm down if he’s violent and aggressive. When you are in that situation and somebody is attacking you . . . . it’s very scary and some people can get hurt . . . . [I]f people are being extremely violent and dangerous and it’s putting the lives of other patients on the ward in jeopardy, if it’s putting the life of staff that are mainly just middle aged women trying to control a very strong aggressive man who is very muscular and knows Karate and is very impulsive and nobody is there to help them . . . it’s a very dangerous and precarious situation.

(Ansari Dep. 50:17–52:23.) Shortly afterwards, however, Tarik was involved in physical altercations on September 1 and September 2, 2015. (Pl.’s Suppl. SUMF at 22–23.) And as a result, Defendant Ansari discontinued Tarik’s Thorazine on September 3 because it “didn’t help him [and] he was still aggressive.” (Ansari Dep. 61:22–63:6 (“There was no benefit to that medication. I was concerned if [sic] he was getting worse. He doesn’t communicate well because of his traumatic brain injury. . . . It’s trying to figure out what’s going on with somebody.”).) 4 For the next few weeks, Tarik was off Thorazine, but his behavior did not change much. (See Pl.’s Suppl. SUMF at 23–24.) Defendant Ansari described Tarik’s behavior as unstable, violent, and aggressive on September 16; and bizarre, unpredictable, and assaultive on October 23. (Id. at 24.) And during the weekend of October 23, Tarik attempted to bite a staff member.

(Id. at 23–24.) Defendant Ansari testified that Tarik had become “quite violent . . . . paranoid, disorganized, aggressive towards both peers and staff,” and “very threatening.” (Ansari Dep. 67:9–68:10.) As a result, on October 26, 2015, Defendant Ansari put Tarik back on Thorazine and ordered “two-to-one precaution,” wherein only male staff would interact with Tarik.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell v. Wolfish
441 U.S. 520 (Supreme Court, 1979)
Youngberg v. Romeo Ex Rel. Romeo
457 U.S. 307 (Supreme Court, 1982)
Harlow v. Fitzgerald
457 U.S. 800 (Supreme Court, 1982)
Daniels v. Williams
474 U.S. 327 (Supreme Court, 1986)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
County of Sacramento v. Lewis
523 U.S. 833 (Supreme Court, 1998)
Tennessee v. Lane
541 U.S. 509 (Supreme Court, 2004)
Nicini v. Morra
212 F.3d 798 (Third Circuit, 2000)
Bowers v. National Collegiate Athletic Association
475 F.3d 524 (Third Circuit, 2007)
Peter Bistrian v. Troy Levi
696 F.3d 352 (Third Circuit, 2012)
Cheryl James v. Wilkes Barre City
700 F.3d 675 (Third Circuit, 2012)
Mary Burton v. Teleflex Inc
707 F.3d 417 (Third Circuit, 2013)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Giles v. Kearney
571 F.3d 318 (Third Circuit, 2009)
Bayer v. Monroe County Children and Youth Services
577 F.3d 186 (Third Circuit, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
PRATT v. ANN KLEIN FORENSIC CENTER, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pratt-v-ann-klein-forensic-center-njd-2019.